Logo image of MLNK

MERIDIANLINK INC (MLNK) Stock Fundamental Analysis

USA - NYSE:MLNK - US58985J1051 - Common Stock

20.025 USD
+0.01 (+0.07%)
Last: 10/23/2025, 2:45:39 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MLNK. MLNK was compared to 285 industry peers in the Software industry. While MLNK seems to be doing ok healthwise, there are quite some concerns on its profitability. MLNK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MLNK had positive earnings in the past year.
In the past year MLNK had a positive cash flow from operations.
MLNK had negative earnings in 4 of the past 5 years.
In the past 5 years MLNK always reported a positive cash flow from operatings.
MLNK Yearly Net Income VS EBIT VS OCF VS FCFMLNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

MLNK has a Return On Assets (-2.40%) which is in line with its industry peers.
With a Return On Equity value of -5.73%, MLNK perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
MLNK's Return On Invested Capital of 1.00% is fine compared to the rest of the industry. MLNK outperforms 63.16% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MLNK is significantly below the industry average of 11.90%.
Industry RankSector Rank
ROA -2.4%
ROE -5.73%
ROIC 1%
ROA(3y)-2.41%
ROA(5y)-2.58%
ROE(3y)-5.04%
ROE(5y)-5.86%
ROIC(3y)1.67%
ROIC(5y)2.77%
MLNK Yearly ROA, ROE, ROICMLNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

The Operating Margin of MLNK (3.38%) is better than 66.32% of its industry peers.
MLNK's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 66.39%, MLNK perfoms like the industry average, outperforming 45.61% of the companies in the same industry.
MLNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.38%
PM (TTM) N/A
GM 66.39%
OM growth 3Y-42.83%
OM growth 5Y-27.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.99%
MLNK Yearly Profit, Operating, Gross MarginsMLNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MLNK is destroying value.
MLNK has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MLNK has less shares outstanding
MLNK has a worse debt/assets ratio than last year.
MLNK Yearly Shares OutstandingMLNK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MLNK Yearly Total Debt VS Total AssetsMLNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.60, we must say that MLNK is in the distress zone and has some risk of bankruptcy.
MLNK has a Altman-Z score (1.60) which is comparable to the rest of the industry.
The Debt to FCF ratio of MLNK is 5.25, which is a neutral value as it means it would take MLNK, 5.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.25, MLNK is in line with its industry, outperforming 59.30% of the companies in the same industry.
A Debt/Equity ratio of 1.18 is on the high side and indicates that MLNK has dependencies on debt financing.
MLNK has a worse Debt to Equity ratio (1.18) than 76.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 5.25
Altman-Z 1.6
ROIC/WACC0.09
WACC11.29%
MLNK Yearly LT Debt VS Equity VS FCFMLNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 2.01 indicates that MLNK has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.01, MLNK is doing good in the industry, outperforming 60.70% of the companies in the same industry.
MLNK has a Quick Ratio of 2.01. This indicates that MLNK is financially healthy and has no problem in meeting its short term obligations.
MLNK has a better Quick ratio (2.01) than 61.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 2.01
MLNK Yearly Current Assets VS Current LiabilitesMLNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 500.00% over the past year.
The Revenue has been growing slightly by 5.96% in the past year.
Measured over the past years, MLNK shows a quite strong growth in Revenue. The Revenue has been growing by 15.68% on average per year.
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%225%
Revenue 1Y (TTM)5.96%
Revenue growth 3Y5.72%
Revenue growth 5Y15.68%
Sales Q2Q%7.53%

3.2 Future

MLNK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.86% yearly.
MLNK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.56% yearly.
EPS Next Y61.5%
EPS Next 2Y40.96%
EPS Next 3Y35.86%
EPS Next 5YN/A
Revenue Next Year5.02%
Revenue Next 2Y5.23%
Revenue Next 3Y5.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MLNK Yearly Revenue VS EstimatesMLNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
MLNK Yearly EPS VS EstimatesMLNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 55.63 indicates a quite expensive valuation of MLNK.
Compared to the rest of the industry, the Price/Earnings ratio of MLNK is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.57. MLNK is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 41.99, MLNK can be considered very expensive at the moment.
MLNK's Price/Forward Earnings ratio is in line with the industry average.
MLNK is valuated expensively when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 55.63
Fwd PE 41.99
MLNK Price Earnings VS Forward Price EarningsMLNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MLNK is valued a bit cheaper than 76.84% of the companies in the same industry.
MLNK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MLNK is cheaper than 84.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.66
EV/EBITDA 26.86
MLNK Per share dataMLNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

MLNK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MLNK's earnings are expected to grow with 35.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)N/A
EPS Next 2Y40.96%
EPS Next 3Y35.86%

0

5. Dividend

5.1 Amount

No dividends for MLNK!.
Industry RankSector Rank
Dividend Yield N/A

MERIDIANLINK INC

NYSE:MLNK (10/23/2025, 2:45:39 PM)

20.025

+0.01 (+0.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)10-29 2025-10-29/amc
Inst Owners39.22%
Inst Owner Change0%
Ins Owners4.35%
Ins Owner Change0.1%
Market Cap1.48B
Revenue(TTM)325.89M
Net Income(TTM)-22494000
Analysts53.85
Price Target20.36 (1.67%)
Short Float %4.08%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.09%
Min EPS beat(2)-23.27%
Max EPS beat(2)27.45%
EPS beat(4)2
Avg EPS beat(4)-6.22%
Min EPS beat(4)-30.14%
Max EPS beat(4)27.45%
EPS beat(8)3
Avg EPS beat(8)-36.84%
EPS beat(12)4
Avg EPS beat(12)0.28%
EPS beat(16)6
Avg EPS beat(16)11.07%
Revenue beat(2)1
Avg Revenue beat(2)0.25%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)1.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)1.58%
Revenue beat(8)1
Avg Revenue beat(8)-0.94%
Revenue beat(12)3
Avg Revenue beat(12)-0.96%
Revenue beat(16)6
Avg Revenue beat(16)-0.02%
PT rev (1m)0%
PT rev (3m)4.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.61%
EPS NY rev (1m)-1.3%
EPS NY rev (3m)0.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 55.63
Fwd PE 41.99
P/S 4.55
P/FCF 16.66
P/OCF 15.38
P/B 3.77
P/tB N/A
EV/EBITDA 26.86
EPS(TTM)0.36
EY1.8%
EPS(NY)0.48
Fwd EY2.38%
FCF(TTM)1.2
FCFY6%
OCF(TTM)1.3
OCFY6.5%
SpS4.4
BVpS5.31
TBVpS-5.33
PEG (NY)0.9
PEG (5Y)N/A
Graham Number6.56
Profitability
Industry RankSector Rank
ROA -2.4%
ROE -5.73%
ROCE 1.27%
ROIC 1%
ROICexc 1.12%
ROICexgc N/A
OM 3.38%
PM (TTM) N/A
GM 66.39%
FCFM 27.28%
ROA(3y)-2.41%
ROA(5y)-2.58%
ROE(3y)-5.04%
ROE(5y)-5.86%
ROIC(3y)1.67%
ROIC(5y)2.77%
ROICexc(3y)1.8%
ROICexc(5y)2.98%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.11%
ROCE(5y)3.5%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-38.18%
ROICexc growth 5Y-18.44%
OM growth 3Y-42.83%
OM growth 5Y-27.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 5.25
Debt/EBITDA 6.7
Cap/Depr 12.8%
Cap/Sales 2.28%
Interest Coverage 0.31
Cash Conversion 139.43%
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 2.01
Altman-Z 1.6
F-Score6
WACC11.29%
ROIC/WACC0.09
Cap/Depr(3y)15.92%
Cap/Depr(5y)15.49%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%225%
EPS Next Y61.5%
EPS Next 2Y40.96%
EPS Next 3Y35.86%
EPS Next 5YN/A
Revenue 1Y (TTM)5.96%
Revenue growth 3Y5.72%
Revenue growth 5Y15.68%
Sales Q2Q%7.53%
Revenue Next Year5.02%
Revenue Next 2Y5.23%
Revenue Next 3Y5.56%
Revenue Next 5YN/A
EBIT growth 1Y-41.37%
EBIT growth 3Y-39.56%
EBIT growth 5Y-16.36%
EBIT Next Year74.11%
EBIT Next 3Y25.17%
EBIT Next 5YN/A
FCF growth 1Y72.85%
FCF growth 3Y-5.78%
FCF growth 5Y34.88%
OCF growth 1Y57.66%
OCF growth 3Y-4.68%
OCF growth 5Y28.98%